Daniel Lochner, Chief Financial Officer at Oyster Point Pharma, Inc. (OYST), bought 6,300 shares at $16.00 ($101K) on 2019-11-04, disclosed to the SEC on 2019-11-05.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |